Exclusive Interview with Riccardo Braglia, Chairman of HAS Healthcare Advanced Synthesis SA
Insights on Strategic Growth & Innovation
In this latest interview, Riccardo Braglia, Chairman of HAS Group, shares valuable insights into the company’s latest developments, strategic motivations, and future plans. We discuss the impactful acquisition of Cerbios-Pharma SA, technological advancements, capacity expansions, sustainability initiatives, and the role of 65 Equity Partners.
Don’t miss this comprehensive update on HAS Group’s vision and future trajectory.